UroGen Pharma Ltd. (URGN) rose 5.64% or 2.47 to $46.25. It is near 22934 shares traded, which is 37.4% compare to the average total volume 61323. The market cap of URGN is $733.21 million. The year to date change is 18.94%. The 52 week price range is from $35.5 to $69.57. Price of URGN have changed 9.70% during last week. It have changed -3.06% over last month, -3.29% over last 3 months, -29.40% over last 6 months and 18.90% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 44.78. It is -3.18% below current price. The 200-day Moving Averages for URGN is 51.04. It is 10.36% above current price. The 52-week High is 69.57. It is 50.42% from the current price. The 52-week Low is 35.5. It is -23.24% from current price.
There are some statistics of URGN. It is has market cap $733.21 million. The share outstanding is 15.85 million. The average volume is 61323. The revenue is 7.81M. The gross profit is 7.52M. The percent of top 15 Institution holding is 13.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -44.15%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -41.31%.